157 related articles for article (PubMed ID: 27186942)
1. Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?
Coates TD; Carson S; Wood JC; Berdoukas V
Ann N Y Acad Sci; 2016 Mar; 1368(1):95-106. PubMed ID: 27186942
[TBL] [Abstract][Full Text] [Related]
2. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
3. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
Kontoghiorghe CN; Kontoghiorghes GJ
Drug Des Devel Ther; 2016; 10():465-81. PubMed ID: 26893541
[TBL] [Abstract][Full Text] [Related]
5. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
[TBL] [Abstract][Full Text] [Related]
6. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
[TBL] [Abstract][Full Text] [Related]
7. Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies.
Porter JB; Shah FT
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1109-30. PubMed ID: 21075283
[TBL] [Abstract][Full Text] [Related]
8. Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.
Angelucci E; Pilo F
Ann N Y Acad Sci; 2016 Mar; 1368(1):115-21. PubMed ID: 26999450
[TBL] [Abstract][Full Text] [Related]
9. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
[TBL] [Abstract][Full Text] [Related]
10. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
Gumus E; Abbasoglu O; Tanyel C; Gumruk F; Ozen H; Yuce A
Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28211259
[TBL] [Abstract][Full Text] [Related]
12. Iron toxicity and its possible association with treatment of Cancer: lessons from hemoglobinopathies and rare, transfusion-dependent anemias.
Puliyel M; Mainous AG; Berdoukas V; Coates TD
Free Radic Biol Med; 2015 Feb; 79():343-51. PubMed ID: 25463277
[TBL] [Abstract][Full Text] [Related]
13. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and management of iron toxicity in thalassemia.
Hershko C
Ann N Y Acad Sci; 2010 Aug; 1202():1-9. PubMed ID: 20712765
[TBL] [Abstract][Full Text] [Related]
15. Current recommendations for chelation for transfusion-dependent thalassemia.
Kwiatkowski JL
Ann N Y Acad Sci; 2016 Mar; 1368(1):107-14. PubMed ID: 27186943
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes: iron overload consequences and current chelating therapies.
Greenberg PL
J Natl Compr Canc Netw; 2006 Jan; 4(1):91-6. PubMed ID: 16403408
[TBL] [Abstract][Full Text] [Related]
18. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
19. National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.
Voskaridou E; Kattamis A; Fragodimitri C; Kourakli A; Chalkia P; Diamantidis M; Vlachaki E; Drosou M; Lafioniatis S; Maragkos K; Petropoulou F; Eftihiadis E; Economou M; Klironomos E; Koutsouka F; Nestora K; Tzoumari I; Papageorgiou O; Basileiadi A; Lafiatis I; Dimitriadou E; Kalpaka A; Kalkana C; Xanthopoulidis G; Adamopoulos I; Kaiafas P; Mpitzioni A; Goula A; Kontonis I; Alepi C; Anastasiadis A; Papadopoulou M; Maili P; Dionisopoulou D; Tsirka A; Makis A; Kostaridou S; Politou M; Papassotiriou I;
Ann Hematol; 2019 Jan; 98(1):55-66. PubMed ID: 30196444
[TBL] [Abstract][Full Text] [Related]
20. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications.
Remacha ÁF; Arrizabalaga B; Villegas A; Durán MS; Hermosín L; de Paz R; Garcia M; Diez Campelo M; Sanz G;
Ann Hematol; 2015 May; 94(5):779-87. PubMed ID: 25516455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
